Dr Melanie Lee CBE steps down as CEO of LifeArc
Dr. Melanie Lee has notified the Board of her decision to step down as Chief Executive Officer,…
Twitter outputted an error:
Invalid or expired token..
Invalid or expired token..
LifeArc welcomes news of the UK rejoining Horizon Europe, the EU science research scheme
Today the UK and EU agreed a deal for the UK to associate the world’s largest collaborative…
LifeArc and the Francis Crick Institute partner with five African research institutions to support scientists
LifeArc is partnering with the Francis Crick Institute to invest £7.5m to support African scientists to address unmet…
LifeArc joins Infection Innovation Consortium to help tackle infectious diseases
LifeArc are partnering with Liverpool School of Tropical Medicine (LSTM) to launch a new development fund to…
LifeArc and DEBRA Austria launch £2.5m funding call for repurposing therapies for Epidermolysis Bullosa
Joint initiative part of LifeArc’s £100 million Translational Challenge to help address rare disease translational science.
Groundbreaking new £100m LifeArc programme aims to improve the lives of people living with a rare disease
Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures
New UK-based research project brings together world-leading institutions to transform care for people living with dementia
Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures
LifeArc strengthens Board of Trustees with new appointments
Dr Terri Cooper, Dr Sameer Mistry and Dr Rima Makarem join LifeArc's Board of Trustees as Non-Executive Directors.
New programme to move potential MND drugs into clinical trials faster
EXPERTS-ALS to screen candidate drugs at scale and identify those that should be fast-tracked to larger clinical trials